These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27363811)

  • 21. Boronate-crosslinked polysaccharide conjugates for pH-responsive and targeted drug delivery.
    Zhang YH; Zhang YM; Yu J; Wang J; Liu Y
    Chem Commun (Camb); 2019 Jan; 55(8):1164-1167. PubMed ID: 30632564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
    Müller K; Kessel E; Klein PM; Höhn M; Wagner E
    Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient delivery of NF-κB siRNA to human retinal pigment epithelial cells with hyperbranched cationic polysaccharide derivative-based nanoparticles.
    Liu Z; Gong H; Zeng R; Liang X; Zhang LM; Yang L; Lan Y
    Int J Nanomedicine; 2015; 10():2735-49. PubMed ID: 25897219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bridge to silencing: Co-assembling anionic nanoparticles of siRNA and hyaluronan sulfate via calcium ion bridges.
    Forti E; Kryukov O; Elovic E; Goldshtein M; Korin E; Margolis G; Felder S; Ruvinov E; Cohen S
    J Control Release; 2016 Jun; 232():215-27. PubMed ID: 27117458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide-gold nanocluster supramolecular conjugates as a versatile platform for the targeted delivery of anticancer drugs.
    Li N; Chen Y; Zhang YM; Yang Y; Su Y; Chen JT; Liu Y
    Sci Rep; 2014 Feb; 4():4164. PubMed ID: 24566666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.
    Cristofolini T; Dalmina M; Sierra JA; Silva AH; Pasa AA; Pittella F; Creczynski-Pasa TB
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110555. PubMed ID: 32228895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialic acid-targeted cyclodextrin-based nanoparticles deliver CSF-1R siRNA and reprogram tumour-associated macrophages for immunotherapy of prostate cancer.
    Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
    Eur J Pharm Sci; 2023 Jun; 185():106427. PubMed ID: 36948408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-assembly of poly(allylamine)/siRNA nanoparticles, their intracellular fate and siRNA delivery.
    Di Silvio D; Martínez-Moro M; Salvador C; de Los Angeles Ramirez M; Caceres-Velez PR; Ortore MG; Dupin D; Andreozzi P; Moya SE
    J Colloid Interface Sci; 2019 Dec; 557():757-766. PubMed ID: 31569055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Arima H
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1113-1121. PubMed ID: 28964842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
    Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
    Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
    Rahme K; Guo J; Holmes JD
    Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ternary complexes of folate-PEG-appended dendrimer (G4)/α-cyclodextrin conjugate, siRNA and low-molecular-weight polysaccharide sacran as a novel tumor-selective siRNA delivery system.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Int J Biol Macromol; 2017 Jun; 99():21-28. PubMed ID: 28223132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
    Yang J; Zhao R; Feng Q; Zhuo X; Wang R
    Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
    Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.